Cargando…
The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer
Autophagy is an intracellular catabolic process that is increasingly being recognized as a crucial factor in several human diseases including cancers. Mounting evidence suggests that autophagy allows tumor cells to overcome otherwise fatal stresses and to increase dissemination. Nevertheless, how au...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344152/ https://www.ncbi.nlm.nih.gov/pubmed/32714931 http://dx.doi.org/10.3389/fcell.2020.00545 |
_version_ | 1783555884279922688 |
---|---|
author | Damiano, Valentina Spessotto, Paola Vanin, Giulia Perin, Tiziana Maestro, Roberta Santarosa, Manuela |
author_facet | Damiano, Valentina Spessotto, Paola Vanin, Giulia Perin, Tiziana Maestro, Roberta Santarosa, Manuela |
author_sort | Damiano, Valentina |
collection | PubMed |
description | Autophagy is an intracellular catabolic process that is increasingly being recognized as a crucial factor in several human diseases including cancers. Mounting evidence suggests that autophagy allows tumor cells to overcome otherwise fatal stresses and to increase dissemination. Nevertheless, how autophagy controls these processes and in particular how it impinges on cell-cell adhesion is still poorly understood. Here, we investigate the role of autophagy in the turnover of the epithelial adhesion molecule E-cadherin in the context of breast cancer. We demonstrated in breast cancer cell lines that autophagy impinges on E-cadherin expression and in the configuration of adherens junctions. Besides, we showed that E-cadherin colocalizes with LC3B and SQSTM1/p62, two components of the autophagosome machinery. Pull down and immunoprecipitation analyses provided evidence that E-cadherin and SQSTM1/p62 physically interact. Moreover, the physical closeness of E-cadherin and SQSTM1/p62 was demonstrated by proximity ligation assays in breast cancer cell lines and primary tumors. Finally, we proved that the silencing of SQSTM1/p62 diminished the E-cadherin/LC3B colocalization, further supporting the role of SQSTM1/p62 in E-cadherin delivery to autophagosomes. These findings suggest that the activation of autophagy, reported in breast cancers with poor prognosis and in dormant breast cancer cells, may contribute to the control of tumor progression via downmodulation of E-cadherin protein levels. |
format | Online Article Text |
id | pubmed-7344152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73441522020-07-25 The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer Damiano, Valentina Spessotto, Paola Vanin, Giulia Perin, Tiziana Maestro, Roberta Santarosa, Manuela Front Cell Dev Biol Cell and Developmental Biology Autophagy is an intracellular catabolic process that is increasingly being recognized as a crucial factor in several human diseases including cancers. Mounting evidence suggests that autophagy allows tumor cells to overcome otherwise fatal stresses and to increase dissemination. Nevertheless, how autophagy controls these processes and in particular how it impinges on cell-cell adhesion is still poorly understood. Here, we investigate the role of autophagy in the turnover of the epithelial adhesion molecule E-cadherin in the context of breast cancer. We demonstrated in breast cancer cell lines that autophagy impinges on E-cadherin expression and in the configuration of adherens junctions. Besides, we showed that E-cadherin colocalizes with LC3B and SQSTM1/p62, two components of the autophagosome machinery. Pull down and immunoprecipitation analyses provided evidence that E-cadherin and SQSTM1/p62 physically interact. Moreover, the physical closeness of E-cadherin and SQSTM1/p62 was demonstrated by proximity ligation assays in breast cancer cell lines and primary tumors. Finally, we proved that the silencing of SQSTM1/p62 diminished the E-cadherin/LC3B colocalization, further supporting the role of SQSTM1/p62 in E-cadherin delivery to autophagosomes. These findings suggest that the activation of autophagy, reported in breast cancers with poor prognosis and in dormant breast cancer cells, may contribute to the control of tumor progression via downmodulation of E-cadherin protein levels. Frontiers Media S.A. 2020-06-30 /pmc/articles/PMC7344152/ /pubmed/32714931 http://dx.doi.org/10.3389/fcell.2020.00545 Text en Copyright © 2020 Damiano, Spessotto, Vanin, Perin, Maestro and Santarosa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Damiano, Valentina Spessotto, Paola Vanin, Giulia Perin, Tiziana Maestro, Roberta Santarosa, Manuela The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title | The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title_full | The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title_fullStr | The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title_full_unstemmed | The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title_short | The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer |
title_sort | autophagy machinery contributes to e-cadherin turnover in breast cancer |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344152/ https://www.ncbi.nlm.nih.gov/pubmed/32714931 http://dx.doi.org/10.3389/fcell.2020.00545 |
work_keys_str_mv | AT damianovalentina theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT spessottopaola theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT vaningiulia theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT perintiziana theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT maestroroberta theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT santarosamanuela theautophagymachinerycontributestoecadherinturnoverinbreastcancer AT damianovalentina autophagymachinerycontributestoecadherinturnoverinbreastcancer AT spessottopaola autophagymachinerycontributestoecadherinturnoverinbreastcancer AT vaningiulia autophagymachinerycontributestoecadherinturnoverinbreastcancer AT perintiziana autophagymachinerycontributestoecadherinturnoverinbreastcancer AT maestroroberta autophagymachinerycontributestoecadherinturnoverinbreastcancer AT santarosamanuela autophagymachinerycontributestoecadherinturnoverinbreastcancer |